登入選單
返回Google圖書搜尋
註釋This report uses the prevalence-based human capital approach to translate morbidity and premature mortality data into direct and indirect costs to affected individuals and Canadian society. Direct costs include drug expenditures, physician and hospital care costs, and health science research expenditures. Indirect costs include mortality costs and morbidity costs due to short- and long-term disability. Most of the costs were also classified by diagnostic category such as cardiovascular diseases, injuries, and cancer. A portion of the costs of illness could be categorized by sex and age.